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Abstract. Evaluation of immune status of dogs, in different physiological, against two 
of the worst diseases of dogs, it is a necessity as long as contamination is a real nest of 
puppies. In principle, protective immunity correlates with high antibody titres, but any study 
that has such a topic, establish protective serum antibody levels to specific pathogens. A 
major difficulty in the comparative analysis of specific immune response obtained in different 
serological studies is the manner in which antibody titers were determined. Therefore, to 
facilitate further research on the same theme of this paper, it was decided to use a test semi 
quantitatively (dot-ELISA) commercially available, approved by many laboratories. The first 
physiological assessment was undertaken bitches immune response was non-pregnant and 
lactating female dogs. The dynamics of post-vaccination antibody in this category, vaccinated 
up to 12 months before serological evaluation, revealed progressive reduction of protective 
antibody titers to CPV and CDV. The highest antibody titers after vaccination were obtained 
from nonpregnant bitches and non-tested 1-3 months after manage their vaccine, 60% of those 
with titers over 1:650 and 1:160 over 20%. The second physiological condition of bitches 
who did the evaluation of immune response was pregnant bitches. Values post-vaccination 
antibodies to pregnant bitches, stud previously vaccinated were above the minimum threshold 
for CDV and CPV protective, 60% of pregnant with titers of over 1:160 and 40% between 
1:80 and 1:160 titers. The third physiological state of bitches that did the evaluation of 
immune response was lactating bitches. Unlike dogs pregnant group, the group post-
vaccination antibody levels lactating bitches were at the limit of the minimum protective CDV 
(above 1:80) at 60% of test animals and 40% of bitches were in period lactanŃie had 
valuesgreater than 1:160. If anti-CPV IgG titer percentage bitches with the lower limit of 
protection was only 20%, the remaining animals with titers of over 1:160. 
 




Serum immunoglobulin (Ig) serological influenced by environment, and their 
determination allows accurate assessment of immune status in dogs, regardless of their age. 
Normal values published in literature are not uniform, and difficulties may occur when it is 
necessary to interpret the changes occurring at this level (Daneş and Rotaru, 2002a, 2002b; 
AAHA, 2003, Provost et al, 2003). Ottiger et al. (2006) evaluated the serum antibody titer for 
Canine Distemper Virus (CDV) and Canine Parvovirus (CPV) in dogs that were not subject to 
annual immunization protocol and have compared with a control group that was regularly 
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vaccinated. It was noted that 83% of dogs vaccinated against CDV with one or more years 
previously had serum neutralizing antibody titers equal to or greater than 1:16. On the other 
hand, 64% of dogs vaccinated against CPV with one or more years previously had serum 
antibody titers inhibo-haemagglutinating equal to or greater than 1:80. Three weeks after 
vaccination antibody maintenance of these dogs has increased therefore to 96% of dogs for 
CDV and 68% of dogs for CPV (Ottiger et al., 2006). 
In principle, protective immunity correlates with high titers of antibodies in their 
entirety, but any study that has such a topic, establish protective serum antibody levels to 
specific pathogens, CPV and CDV as. Evaluation of immune status of dogs, in different 
physiological, against two of the worst diseases of dogs, is set in a must as long as 
contamination is a real nest of puppies. In principle, protective immunity correlates with high 
antibody titres, but any study that has such a topic, establish protective serum antibody levels 
to specific pathogens. A major difficulty in the comparative analysis of specific immune 
response obtained in different serological studies is the manner in which antibody titers were 
determined. Therefore, to facilitate further research on the same theme of this paper, it was 
decided to use a test semi-quantitatively (dot-ELISA) commercially available, approved by 
many laboratories. 
 
MATERIALS AND METHOD 
 
Status nonpregnant or lactating bitches immune to CPV and CDV vaccination 
Using a protocol similar to that proposed by Waner et al (2006) were sampled a total 
of 20 dogs vaccinated within 12 months with a modified live vaccine (canine parvovirus, 
distemper virus virus, adenovirus, parainfluenŃa virus). Last vaccination was obtained from 
health records or records by the doctor of veterinary medical offices that blood samples for 
research. Bitches were of different races, usually half-breeds, aged between 2 and 6 years. 
IgG antibody titers to CPV and CDV were determined by dot-ELISA with Canine 
Parvovirus & Distemper ImmunoComb® IgG Antibody Test Kit (Biogal, Israel). 
Measurement of immunoglobulin concentration was performed using a kit available 
colorimentrică scale, and interpretation was done according to the manufacturer. The results 
were expressed in units of S on a scale of 0-6. For both parameters measured by this test 
(CPV and CDV), the S = 3 was standardized by the company producing the equivalent value 
titre 1:80 IHA units respectively for CPV and CDV units for HIV-neutralizing. HI and SN 
antibody titers of 1:80 (S = 3) was considered protective for CPV and CDV infection. By 
extrapolation a value S = 1 represents a titer of 1:20 and S = 2 is equivalent titer 1:40. 
For statistical analysis it was decided to group dogs into 4 groups, taking into account 
time since last vaccination and the date the blood sample collection. Also were calculated and 
serum antibody titers for CDV environments and CPV. 
Immune status in pregnant bitches CPV and CDV vaccination 
Using a protocol similar work previously, they identified a total of five pregnant 
bitches, which modified live vaccine (canine parvovirus, canine distemper virus, canine 
adenovirus, canine parainfluenza virus - DHPPI) was administered before mating. Bitches 
were of different races and ages 3 to 7 years. IgG antibody titers to CPV and CDV were 
determined by the same test dot-ELISA. 
Immune status in lactating bitches CPV and CDV vaccination 
Using a protocol similar to that described above work, have identified a number of 
five lactating bitches, where vaccination was previously installed. Bitches were of different 
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races and ages 4 and 6 years. IgG antibody titers to CPV and CDV were determined by the 
same test dot-ELISA. 
 
 
RESULTS AND DISCUSSION 
 
Status nonpregnant or lactating bitches immune to CPV and CDV vaccination 
In the 20 dogs examined were obtained results in Table 1. 
 
Tab. 1. 
Dot-ELISA values CPV & CDV IgG and non nonpregnant bitches 
 
IgG CPV Titer IgG CDV Titer 
 In S units In IH units In S units In IH units 
Lot C1 - vaccinated 1-3 months ago 
F1 4 1:160 4 1:160 
F2 6 1:640 6 1:640 
F3 6 1:640 6 1:640 
F4 3 1:80 4 1:160 
F5 6 1:640 6 1:640 
Lotl C2 - vaccinated 4-6 months ago 
F6 5 1:320 6 1:640 
F7 5 1:320 5 1:320 
F8 5 1:320 4 1:160 
F9 3 1:80 5 1:320 
F10 3 1:80 2 1:40 
Lot C3 - vaccinated 7-9 months ago 
F11 3 1:80 3 1:80 
F12 5 1:320 5 1:320 
F13 5 1:320 5 1:320 
F14 6 1:640 6 1:640 
F15 5 1:320 5 1:320 
Lot C4 - vaccinated within 10-12 months 
F16 3 1:80 3 1:80 
F17 5 1:320 4 1:160 
F18 5 1:320 6 1:640 
F19 3 1:80 4 1:160 
F20 4 1:160 3 1:80 
 
Tab. 2. 
 CPV: IgG statistical parameters in nonpregnant and nonlactant bitches  
 
Lots 
 Total C1 C2 C3 C4 
No. bitches 20 5 5 5 5 
Average S Titer - 5 4,2 4,8 4 
Standard deviation - 1,4 1,1 1,1 1 
% protected 70% 80% 60% 80% 60% 
% to the imunity limity 30% 20% 40% 20% 40% 
% unprotected 0% 0% 0% 0% 0% 
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Evaluation of immune status was done on batches of five females, every 3 months 
after the last vaccination, statistical analysis focusing on the comparison of data from each 
group and average titers obtained in each batch. 
 
Time since last vaccination: from 0 to 12 months 
Fig. 1. The trend in the mean titers for CPV and S deviation for their standard in the 4 lots of 
non-pregnant and non-lactating bitches (Blue line - Average S Titers of C lots; Red line – 
standard deviation) 
 
The chart above we see that there is no linear correlation between the four groups of 
environments investigated, although standard deviation was low. Standard deviation does not 
give information on absolute performance of a group of women scientists but indicates the 
degree of uniformity of results in all groups post-vaccination titers. 
 
Tab. 3. 
CDV: IgG statistical parameters and in non-pregnant and non-lactant bitches 
 
Lots 
 Total C1 C2 C3 C4 
No. bitches 20 5 5 5 5 
Average S Titer - 5,2 4,4 4,8 4 
Standard deviation - 1,1 1,5 1,1 1,2 
% protected 80% 100% 80% 80% 60% 
% to the imunity limity 15% 0% 0% 20% 40% 
% unprotected 5% 0% 20% 0% 0% 
 
 
Time since last vaccination: from 0 to 12 months 
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Fig. 2. Time trend of the average S titers for CDV and their standard deviation to the 4 lots of 
non-pregnant and lactating (Blue line - Average S Titers of C lots; Red line – standard 
deviation) 
 
As for canine parvovirus has not been a linear correlation of S CDV-Ab titers 
environments in the 4 groups of non-pregnant and / or dairy. Taking into account the standard 
deviations obtained, having a high linearity of the value obtained for canine parvovirus, 
uniformity of results is below the one for parvovirus. 
 
Immune status in pregnant bitches CPV and CDV vaccinated 
In the five pregnant bitches were obtained by dot-ELISA test with bivalent CPV / 
CDV results in the table below. 
Tab. 4. 
Dot-ELISA values CPV & CDV IgG in pregnant bitches 
  
IgG CPV Titer IgG CDV Titer 
 In S units In IH units In S units In SN units 
Lot C5 - pregnant 
F21 5 1:320 5 1:320 
F22 3 1:80 4 1:160 
F23 4 1:160 4 1:160 
F24 3 1:80 3 1:80 
F25 4 1:160 3 1:80 
 
Tab. 5. 
CPV: ICG statistical parameters statisticians in pregnant bitches 
 
 Total Lot C5 
No. bitches 5 5 
Average S Titer - 3,8 
Standard deviation - 0,84 
% protected 60% 60% 
% to the immunity limit 40% 40% 
% unprotected 0% 0% 
 
Tab. 6. 
CDV: IgG statistical parameters statisticians in pregnant bitches 
 
 Total Lotul C5 
No. bitches 5 5 
Average S Titer - 3,8 
Standard deviation - 0,84 
% protected 60% 60% 
% to the immunity limit 40% 40% 
% unprotected 0% 0% 
 
Immune status in lactating bitches CPV and CDV vaccinated 
At the 5 lactating bitches IgG titers were obtained, presented in S and IH units (CPV), 
SN (CDV) in Table 7. 
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Tab. 7. 
CPV & CDV IgG Dot-ELISA values in lactating bitches  
 
IgG CPV Titer IgG CDV Titer 
 In S units In IH units In S units In SN units 
Lot C5 - pregnant 
F26 4 1:160 3 1:80 
F27 4 1:160 3 1:80 
F28 4 1:160 4 1:160 
F29 3 1:80 3 1:80 
F30 4 1:160 4 1:160 
Statistical data analysis is presented in Tables 8 and 9. 
Tab. 8. 
CPV: IgG statistical parameters in lactant bitches 
 
 Total Lot C6 
No. bitches 5 5 
Average S Titer - 3,8 
Standard deviation - 0,44 
% protected 80% 80% 
% to the immunity limit 20% 20% 
% unprotected 0% 0% 
 
Tab. 9. 
CDV: IgG Statistical parameters in lactating bitches 
 
 Total Lot C6 
No. bitches 5 5 
Average S Titer - 3,4 
Standard deviation - 0,55 
% protected 40% 40% 
% to the immunity limit 60% 60% 
% unprotected 0% 0% 
Analysis of immune status in bitches under normal physiological conditions in 
different  
Regardless of the physiological state, bitches vaccinated up to a year ago IgG titre 
maintain CPV and CDV above the minimum protective (set in the present research to S3 = 
1:80). There is a slight decrease in average IgG titers S to pregnant and lactating CPV, but 
without affecting their immune protection (serological titres remain above the cut-off). This is 
more clearly observed when IgG titers of CDV S, where the dairy obtained the lowest values 
of serum IgG CDV. 
Tab. 10 
CPV: IgG statistical parameters in bitches with different physiologic statuses 
 
 S1 (C1,C2,C3,C4) C5 C6 
Average S titer  4.5 3.8 3.8 




Fig. 3. Average of the S titers for CPV and IgG titers Media S and their standard deviation to 





CDV: IgG statistical parameters in bitches with different physiological statuses 
 
 S1 (C1,C2,C3,C4) C5 C6 
Average S titer  4.6 3.8 3.4 
Standard deviation 1.23 0.84 0.55 
 
 
Fig. 4. Average of the S titers for CDV and IgG titers and their standard deviation to the 
bitches in different physiological statuses (Blue blocs - Average S titer; Red blocs - Standard 
deviation) 
 
A major difficulty in the comparative analysis of specific immune response obtained 
in different serological studies is the manner in which antibody titers were determined. Dot-
ELISA method is a semi-quantitative method based on comparing the color of a standard 
color test sample results. Studies to date have shown a good correlation of HI and CDV SN 
titers to CPV values S of dot-ELISA test (Waner et al., 1996, 1998). 
A dot-ELISA method limit is to determine accurately the values of titres from 1:10 to 
1:40 (Waner et al., 1996). This shortcoming is not considered to be a problem for determining 
protective antibody titers when the titre is defined as ≥ 1:80. On the other hand, setting the 
protective titer at this level that can be removed relatively high percentage of dogs which, 
although protected immune is CPV antibody titers and / or CDV at the limit. Dogs that exhibit 
borderline titers is expected to be between 1:20 to 1:40 (S = 1 and S = 2). The fact that these 
dogs have specific antibodies is evidence that they were previously exposed to CPV and 
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CDV, either naturally or by vaccination. Despite the low antibody titer, it is possible that 
these dogs to be well-protected. Evidence of this situation are given to studies that have found 
that immune protection against CPV and CDV were obtained after two vaccinations 7-8 
weeks started life (Abdelmagid et al., 2004). However, to clarify this aspect should be made 
more detailed studies in the future. 
Considering these observations, it was observed that if the percentage of dogs with 
protective titers (S≥3) and those with titers S = 2 (equivalent to 1:40) for CPV and CDV is 
accumulated, the percentage protect dogs will greatly increase: over 92% for CPV and 89% 
for CDV (Waner et al., 2006). With dot-ELISA kit, Waner et al. (2006) identified a 
significant number of dogs that had titers to CPV and CDV annual revaccination is still 
protective. Quantifying the level of antibodies is a necessary feature of a test to determine IgG 
antibody recognition of dogs with or without protection of a certain disease, and this was 
possible in research based on dot-ELISA method. In a recent study Bohm et al. chose 
HI≥1:128 CPV value, but other studies cut-off value was set at 1:80 (Bohm et al., 2004). For 
CDV, Bohm et al. chose a SN titer of 1:64 or greater, even if SN titers ranging between 1:16 
to 1:32 proved to be protective (Coyne et al. 2001; Olson et al. 1988). Another study sought to 
identify remaining seropositive dogs or respond to revaccination 5 serological viral antigens 
long after the last vaccination, dogs were considered protected CDV SN titers to CPV HI 
titers ≥ 1:32 and ≥ 1 : 80 (Mouzin et al., 2004). In our research, which used the dot-ELISA 
method, protective titer was determined for both CPV and CDV as to ≥ 1:80. This strength is 
slightly lower than that chosen by some researchers, but higher by a factor or more than titers 




• Post-vaccination serologic antibody titer was maintained in most nonpregnant bitches and 
dairy (80% of bitches investigated), more than the minimum protective titer with S 
medium from 4.0 to 5.2. Only 5% of these were not immunologically protected, but at 4-6 
months post-vaccination. These results suggest that immune-prophylaxis, the post-
vaccination immune response may be influenced by several factors, which may occur 
randomly at any time during the period considered theoretically to be protective for CPV 
and CDV. 
• The group of non-pregnant and non-bitches, the highest CPV and CDV antibody titers 
were obtained at 1-3 months post vaccination, 60% of animals tested with IgG titers above 
1:650 and 20% titers above 1: 160. 
• Post-vaccination antibodies to pregnant bitches values were above the minimum threshold 
for CDV and CPV protective, 60% of pregnant with titers of over 1:160 and 40% between 
1:80 and 1:160 titers, both IgG anti-CDV and the IgG anti-CPV. 
• The group post-vaccination antibody levels lactating bitches were at the limit of the 
minimum protective CDV (above 1:80) at 60% of test animals and 40% of bitches in 
lactation period had values greater than 1: 160. If anti-CPV IgG titer percentage bitches 
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